Abstract
Multivessel disease (MVD) is a challange for both interventional cardiologists and cardiovascular surgeons. Despite all the remarkable progress of modern medicine, this condition frequently requires surgical myocardial revascularization in the drug-eluting stent era. Coronary artery bypass grafting is known to improve survival. However, in patients with MVD, the fate of the graft is negatively influenced by a cumulation of risk factors. The use of multiple conduits with specific long-term patencies, the technical aspects regarding the complexity of the procedure including personal technical skills but also institutional facilities and associated comorbidities that promote accelerated atherosclerosis lead to an increased risk of graft failure in patients with MVD.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Hueb W, Lopes N, Gersh B, et al. Ten-year follow-up survival of the Medicine, Angioplasty or Surgery Study (MASS II). A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2010;122:949–57.
Sipahi I, Akay MH, Dagdelen S, et al. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era. JAMA Intern Med. 2014;174(2):223–30.
Garcia S, Sandoval Y, Roukoz H, et al. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies. JACC. 2013;62(16):1421–31.
Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360:213–24.
De Bruyne B. Multivessel disease from reasonably incomplete to functionally complete revascularization. Circulation. 2012;125:2557–9.
Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2014;35:2541–619.
Tatoulis J, Buxton B, Fuller J. Patencies of 2,127 arterial to coronary conduits over 15 years. Ann Thorac Surg. 2004;77:93–101.
Taggart DP. Current status of arterial grafts for coronary artery bypass grafting. Am Cardiothorac Surg. 2013;2(4):427–30.
Locker C, Schaff H, Dearani J, et al. Multiple arterial grafts improve late survival of patients undergoing coronary artery bypass graft surgery. Analysis of 8,622 patients with multivessel disease. Circulation. 2012;126:1023–30.
Lytle BW, Blackstone EH, Sabik JF, et al. The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years. Ann Thorac Surg. 2004;78:2005–12.
Galbut DL, Kurlansky PA, Traad EA, et al. Bilateral internal thoracic artery grafting improves long-term survival in patients with reduced ejection fraction: a propensity-matched study with 30-year follow-up. J Thorac Cardiovasc Surg. 2012;143:844–53.
Benedetto U, Angeloni E, Refice S, et al. Radial artery versus saphenous vein graft patency: meta-analysis of randomized controlled trials. J Thorac Cardiovasc Surg. 2010;139:229–31.
Athanasiou T, Saso S, Rao C, et al. Radial artery versus saphenous vein conduits for coronary artery bypass surgery: forty years of competition-which conduit offers better patency? A systematic review and meta-analysis. Eur J Cardiothorac Surg. 2011;40:208–20.
Hu X, Zhao Q. Systematic comparison of the effectiveness of radial artery and saphenous vein or right internal thoracic artery coronary bypass grafts in non-left anterior descending coronary arteries. J Zhejiang Univ Sci B. 2011;12:273–9.
Cao C, Manganas C, Horton M, et al. Angiographic outcomes of radial artery versus saphenous vein in coronary artery bypass graft surgery: a meta-analysis of randomized controlled trials. J Thorac Cardiovasc Surg. 2013;146:255–61.
Benedetto U, Raja SG, Albanese A, et al. Searching for the second best graft for coronary artery bypass surgery: a network meta-analysis of randomized controlled trials. Eur J Cardiothorac Surg. 2015;47:59–65.
Rankin JS, Tuttle RH, Wechsler AS, et al. Techniques and benefits of multiple internal mammary artery bypass at 20 years of follow-up. Ann Thorac Surg. 2007;83:1008–14.
Kurlansky PA, Traad EA, Dorman MJ, et al. Thirty-year follow-up defines survival benefit for second internal mammary artery in propensity-matched groups. Ann Thorac Surg. 2010;90:101–8.
Tatoulis J, Buxton BF, Fuller JA. The right internal thoracic artery: the forgotten conduit-5,766 patients and 991 angiograms. Ann Thorac Surg. 2011;92:9–15.
Taggart DP, Altman DG, Gray AM, et al. Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularization Trial (ART). Eur Heart J. 2010;31:2470–81.
Al-Sabti HA, Al Kindi A, Al Rasadi K, et al. Saphenous vein graft vs. radial artery graft searching for the best second coronary artery bypass graft. J Saudi Heart Assoc. 2013;25(4):247–54.
Fitzgibbon GM, Kafka HP, Leach AJ, et al. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1996;28:616–26.
Buxton BF, Ruengsakulrach P, Fuller J, et al. The right internal thoracic artery graft-benefits of grafting the left coronary system and native vessels with a high grade stenosis. Eur J Cardiothorac Surg. 2000;18:255–61.
De Paulis R, de Notaris S, Scaffa R, et al. The effect of bilateral internal thoracic artery harvesting on superficial and deep sternal infection: The role of skeletonization. J Thorac Cardiovasc Surg. 2005;129:536–43.
Maniar HS, Sundt TM, Barner HB, et al. Effect of target stenosis and location on radial artery graft patency. J Thorac Cardiovasc Surg. 2002;123:45–52.
Pijls NH, Fearon WF, Tonino PA, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2 –year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol. 2010;56(3):177–84.
Harskamp RE, Alexander JH, Schulte PJ, et al. Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial. JAMA Surg. 2014;149(8):798–805.
Anghel L, Arsenescu Georgescu C. What is hiding the diabetes in the new left bundle branch block patients? Acta Endocrinol (Buc). 2014;10(3):425–34.
Pleşoianu CE, Arsenescu Georgescu C. Heart-ridden diabetes mellitus. Rom J Art Creat. 2013;1(2):238–60.
Lima EG, Hueb W, Garcia RM, et al. Impact of diabetes on 10-year outcomes of patients with multivessel coronary artery disease in the Medicine, Angioplasty, or Surgery Study II (MASS II) trial. Am Heart J. 2013;166(2):250–7.
De Luca G, Schaffer A, Verdoia M, et al. Meta–analysis of 14 trials comparing bypass grafting vs. drug-eluting stents in diabetic patients with multivessel coronary artery disease. Nutr Metab Cardiovasc Dis. 2014;24(4):344–54.
Chikwe J, Castillo JG, Rahmanian PB, et al. The impact of moderate–to-end–stage renal failure on outcomes after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2010;24(4):574–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Georgescu, C.A., Plesoianu, C.E. (2016). Multivessel Disease, Risk of Graft Failure. In: Ţintoiu, I., Underwood, M., Cook, S., Kitabata, H., Abbas, A. (eds) Coronary Graft Failure. Springer, Cham. https://doi.org/10.1007/978-3-319-26515-5_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-26515-5_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-26513-1
Online ISBN: 978-3-319-26515-5
eBook Packages: MedicineMedicine (R0)